MONMOUTH JUNCTION, NJ--(Marketwired - May 1, 2013) - Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases in orphan indications that are often life-threatening, today announced that the Company will release financial results for the three months ended March 31, 2013, before the opening of the stock market on Tuesday, May 7, 2013.
Will Lewis, President and Chief Executive Officer, and Andy Drechsler, Chief Financial Officer, will host a conference call for investors beginning at 8:30 a.m. ET on Tuesday, May 7, 2013 to discuss the first quarter 2013 financial results and to answer questions.
Shareholders and other interested parties may participate in the conference call by dialing 888- 803-5993 (domestic) or 706-634-5454 (international) and referencing conference ID number 56371335. The call will also be broadcast live on the internet on the Company's website